← Open Payments lookup

CHRISTOPHER RHODES: Open Payments

NPI 1538875356 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,421 in 37 payments from 10 companies in 2025. Trend: 2023 $43 · 2024 $178 · 2025 $1,421

Food & beverage: $1,421
CompanyPaymentsAmount
Indivior Inc.9$250
Otsuka Pharmaceutical Development & Commercialization, Inc.3$216
Alkermes, Inc.4$174
Gilead Sciences, Inc.2$156
Otsuka America Pharmaceutical, Inc.9$153
Madrigal Pharmaceuticals1$140
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$140
GlaxoSmithKline, LLC.1$109
Neurocrine BioSciences, Inc.2$66
Merck Sharp & Dohme LLC1$17

Products named: REXULTI, SUBLOCADE, VIVITROL, REZDIFFRA, CAPLYTA, Epclusa, BLUJEPA, INGREZZA.

Industry payments across MA — which companies pay providers there.